The leading Brazilian exchange-traded fund in the U.S. has a constructive technical setup that suggests its recent corrective phase is maturing.
Traders are betting on a comeback quarter for Netflix
Options traders are striking a decidedly bullish tone heading into the streaming giant’s earnings on Thursday.
Four struggling, big name stocks that should rally this earnings season, according to Evercore ISI
The quartet are part of a group that Evercore identified as “beaten-down beat and raisers.”
Disney could rally 40% if it takes this bold step, says Wells Fargo
Disney’s content is getting more valuable while its online distribution business is less competitive, the investment bank said.
Josh Brown has stuck with these two names on his Best Stocks list. It’s paying off
Good ideas are worth sticking with, says Josh Brown. Here are two such stocks.
These two stocks could soon be added to the S&P 500, says KBW
KBW said Rocket is now the sixth-largest company that’s eligible for inclusion in the S&P 500.
Buy the dip on this Chinese EV maker that’s poised for a comeback, says Goldman Sachs
The investment bank upgraded the EV name to buy from neutral.
New drug data could lift shares of this biotechnology stock, Truist says
Biogen could see more upside if it publishes positive results from recent trials linked to kidney and Alzheimer’s treatments, Truist Securities says.
Here are Monday’s biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Netflix, Deckers, Biogen, Nio & more
Here are Monday’s biggest calls on Wall Street.
American Express is a buy despite its expensive valuation, JPMorgan says
The investment bank upgraded American Express to overweight from neutral.